The latest price target for Surgery Partners (NASDAQ:SGRY) was reported by Benchmark on April 21, 2025. The analyst firm set a price target for $35.00 expecting SGRY to rise to within 12 months (a ...

Please see the last page for important GIPS® disclosures. Past performance cannot guarantee future results. Investing involves risk, including the possible loss of principal and fluctuation of ...

Highlights,Ownership adjustments recorded among major stakeholders, including a notable increase by Northern Trust Corp in Surgery Partners.,Key insiders reduced their holdings, reflecting shifts in ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

2025 Adjusted EBITDA Guidance: Reaffirmed at $555 million to $565 million. Surgery Partners Inc (NASDAQ:SGRY) reported first quarter net revenue of $776 million and adjusted EBITDA of $103.9 ...

On Tuesday, Surgery Partners (NASDAQ:SGRY) maintained its Buy rating and $35.00 price target from Benchmark, aligning with the ...

The French Development Agency (AFD) and Morocco’s fertilizer giant OCP Group have signed a €350 million financing agreement to support OCP’s ambitious green investment program, which aims to ...

CEO Eric Evans reported "first quarter net revenue of $776 million and adjusted EBITDA of $103.9 million, both in line with our expectations." Evans stated that compared to the prior year's first ...

Surgery Partners Inc. (SGRY) reported its first-quarter 2025 earnings, revealing a mixed performance with actual earnings per share (EPS) of $0.04, falling short of the forecasted $0.08. The company ...

(RTTNews) - While reporting financial results for the first quarter on Monday, surgical facility owner Surgery Partners, Inc. (SGRY) reaffirmed its revenue and adjusted EBITDA guidance for the ...